While an increasing number of publications have focused on the biology of CD4+CD25+Foxp3+CD45ROlo naive Tregs in GvHD, less attention has been given to iTregs, probably due to the lack of proven cell surface marker that differentiate nTregs from iTregs. The gene discussed is FOXP3; the disease is graft versus host disease.